WHO Good Distribution Practices (GDP) for pharmaceutical products - Annex 5
Click on the titles below for complete guidelines
TABLE OF CONTENTS
5. Regulation of the distribution of pharmaceutical products
6. Organization and management
9. Premises, warehousing and storage
11. Shipment containers and container labelling
13. Transportation and products in transit
15. Repackaging and relabeling
19. Counterfeit pharmaceutical products
1. Introduction
Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are generally responsible for the handling, storage and distribution of such products. In some cases, however, a person or entity is only involved in and responsible for certain elements of the distribution process. The objective of these guidelines is to assist in ensuring the quality and identity of pharmaceutical products during all aspects of the distribution process. These aspects include, but are not limited to, procurement, purchasing, storage, distribution, transportation, repackaging, relabeling, documentation and record-keeping practices.
WHO Good Distribution Practices for pharmaceutical products - Annex 5:
